|
1.
|
Valencia-Sanchez MA, Liu J, Hannon GJ and
Parker R: Control of translation and mRNA degradation by miRNAs and
siRNAs. Genes Dev. 20:515–524. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Zhang L, Hou D, Chen X, et al: Exogenous
plant MIR168a specifically targets mammalian LDLRAP1: evidence of
cross-kingdom regulation by microRNA. Cell Res. 22:107–126. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Ma J and Huang Y: Post-transcriptional
regulation of miRNA biogenesis and functions. Front Biol. 5:32–40.
2010. View Article : Google Scholar
|
|
5.
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Esquela-Kerscher A and Slack FJ: Oncomirs
- microRNAs with a role in cancer. Nat Rev Cancer. 6:259–269. 2006.
View Article : Google Scholar
|
|
7.
|
Garzon R, Calin GA and Croce CM: MicroRNAs
in cancer. Annu Rev Med. 60:167–179. 2009. View Article : Google Scholar
|
|
8.
|
Kwak PB, Iwasaki S and Tomari Y: The
microRNA pathway and cancer. Cancer Sci. 101:2309–2315. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Ming M, Zhao X, Zhao Z, Liu B and Bao J:
MicroRNA regulation of programmed cell death pathways in cancer.
Curr Chem Biol. 6:53–59. 2012.
|
|
10.
|
Loscalzo J, Kohane I and Barabasi AL:
Human disease classification in the postgenomic era: a complex
systems approach to human pathobiology. Mol Syst Biol. 3:1242007.
View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Calin GA, Sevignani C, Dumitru CD, et al:
Human microRNA genes are frequently located at fragile sites and
genomic regions involved in cancers. Proc Natl Acad Sci USA.
101:2999–3004. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Calin GA, Dumitru CD, Shimizu M, et al:
Frequent deletions and down-regulation of micro-RNA genes miR15 and
miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci
USA. 99:15524–15529. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
He L, Thomson JM, Hemann MT, et al: A
microRNA polycistron as a potential human oncogene. Nature.
435:828–833. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Tagawa H and Seto M: A microRNA cluster as
a target of genomic amplification in malignant lymphoma. Leukemia.
19:2013–2016. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Farazi TA, Spitzer JI, Morozov P and
Tuschl T: miRNAs in human cancer. J Pathol. 223:102–115. 2011.
View Article : Google Scholar
|
|
16.
|
Pei Y, Wang Z, Fei F, Shao Z, Huang W and
Zhang X: Bioinformatics study indicates possible microRNA-regulated
pathways in the differentiation of breast cancer. Chin Sci Bull.
55:927–936. 2010. View Article : Google Scholar
|
|
17.
|
Huang da W, Sherman BT, Tan Q, et al: The
DAVID gene functional classification tool: a novel biological
module-centric algorithm to functionally analyze large gene lists.
Genome Biol. 8:R1832007.PubMed/NCBI
|
|
18.
|
Kanehisa M, Araki M, Goto S, et al: KEGG
for linking genomes to life and the environment. Nucleic Acids Res.
36:D480–D484. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Johnson SM, Grosshans H, Shingara J, et
al: RAS is regulated by the let-7 microRNA family. Cell.
120:635–647. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Johnson CD, Esquela-Kerscher A, Stefani G,
et al: The let-7 microRNA represses cell proliferation pathways in
human cells. Cancer Res. 67:7713–7722. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Adams BD, Guttilla IK and White BA:
Involvement of microRNAs in breast cancer. Semin Reprod Med.
26:522–536. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Laios A, O’Toole S, Flavin R, et al:
Potential role of miR-9 and miR-223 in recurrent ovarian cancer.
Mol Cancer. 7:352008. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Lehmann U, Hasemeier B, Christgen M, et
al: Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human
breast cancer. J Pathol. 214:17–24. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Ferretti E, De Smaele E, Po A, et al:
MicroRNA profiling in human medulloblastoma. Int J Cancer.
124:568–577. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Sun Y, Wu J, Wu SH, et al: Expression
profile of microRNAs in c-Myc induced mouse mammary tumors. Breast
Cancer Res Treat. 118:185–196. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Ma L, Young J, Prabhala H, et al: miR-9, a
MYC/MYCN-activated microRNA, regulates E-cadherin and cancer
metastasis. Nat Cell Biol. 12:247–256. 2010.PubMed/NCBI
|
|
27.
|
Bonci D, Coppola V, Musumeci M, et al: The
miR-15a-miR-16-1 cluster controls prostate cancer by targeting
multiple oncogenic activities. Nat Med. 14:1271–1277. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Calin GA, Cimmino A, Fabbri M, et al:
MiR-15a and miR-16-1 cluster functions in human leukemia. Proc Natl
Acad Sci USA. 105:5166–5171. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Mendell JT: miRiad roles for the miR-17-92
cluster in development and disease. Cell. 133:217–222. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Uziel T, Karginov FV, Xie S, et al: The
miR-17∼92 cluster collaborates with the Sonic Hedgehog pathway in
medulloblastoma. Proc Natl Acad Sci USA. 106:2812–2817. 2009.
|
|
31.
|
O’Day E and Lal A: MicroRNAs and their
target gene networks in breast cancer. Breast Cancer Res.
12:2012010.
|
|
32.
|
Lawrie CH, Soneji S, Marafioti T, et al:
MicroRNA expression distinguishes between germinal center B
cell-like and activated B cell-like subtypes of diffuse large B
cell lymphoma. Int J Cancer. 121:1156–1161. 2007. View Article : Google Scholar
|
|
33.
|
Sander S, Bullinger L, Klapproth K, et al:
MYC stimulates EZH2 expression by repression of its negative
regulator miR-26a. Blood. 112:4202–4212. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Kota J, Chivukula RR, O’Donnell KA, et al:
Therapeutic microRNA delivery suppresses tumorigenesis in a murine
liver cancer model. Cell. 137:1005–1017. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35.
|
Visone R, Pallante P, Vecchione A, et al:
Specific microRNAs are downregulated in human thyroid anaplastic
carcinomas. Oncogene. 26:7590–7595. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36.
|
Kim H, Huang W, Jiang X, Pennicooke B,
Park PJ and Johnson MD: Integrative genome analysis reveals an
oncomir/oncogene cluster regulating glioblastoma survivorship. Proc
Natl Acad Sci USA. 107:2183–2188. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37.
|
Gallardo E, Navarro A, Vinolas N, et al:
miR-34a as a prognostic marker of relapse in surgically resected
non-small-cell lung cancer. Carcinogenesis. 30:1903–1909. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
38.
|
Cole KA, Attiyeh EF, Mosse YP, et al: A
functional screen identifies miR-34a as a candidate neuroblastoma
tumor suppressor gene. Mol Cancer Res. 6:735–742. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39.
|
Li N, Fu H, Tie Y, et al: miR-34a inhibits
migration and invasion by down-regulation of c-Met expression in
human hepatocellular carcinoma cells. Cancer Lett. 275:44–53. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
40.
|
Volinia S, Calin GA, Liu CG, et al: A
microRNA expression signature of human solid tumors defines cancer
gene targets. Proc Natl Acad Sci USA. 103:2257–2261. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
41.
|
Yanaihara N, Caplen N, Bowman E, et al:
Unique microRNA molecular profiles in lung cancer diagnosis and
prognosis. Cancer Cell. 9:189–198. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
42.
|
Nakada C, Matsuura K, Tsukamoto Y, et al:
Genome-wide microRNA expression profiling in renal cell carcinoma:
significant down-regulation of miR-141 and miR-200c. J Pathol.
216:418–427. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
43.
|
Du Y, Xu Y, Ding L, et al: Down-regulation
of miR-141 in gastric cancer and its involvement in cell growth. J
Gastroenterol. 44:556–561. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
44.
|
Nie W, Tang L, Zhang H, et al: Structural
analysis of the EGFR TK domain and potential implications for EGFR
targeted therapy. Int J Oncol. 40:1763–1769. 2012.PubMed/NCBI
|
|
45.
|
Adam L, Zhong M, Choi W, et al: miR-200
expression regulates epithelial-to-mesenchymal transition in
bladder cancer cells and reverses resistance to epidermal growth
factor receptor therapy. Clin Cancer Res. 15:5060–5072. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
46.
|
Bendoraite A, Knouf EC, Garg KS, et al:
Regulation of miR-200 family microRNAs and ZEB transcription
factors in ovarian cancer: Evidence supporting a
mesothelial-to-epithelial transition. Gynecol Oncol. 116:117–125.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
47.
|
Gandellini P, Folini M, Longoni N, et al:
miR-205 exerts tumor-suppressive functions in human prostate
through down-regulation of protein kinase Cepsilon. Cancer Res.
69:2287–2295. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
48.
|
Wiklund ED, Bramsen JB, Hulf T, et al:
Coordinated epigenetic repression of the miR-200 family and miR-205
in invasive bladder cancer. Int J Cancer. 128:1327–1334. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
49.
|
Iorio MV, Casalini P, Piovan C, et al:
microRNA-205 regulates HER3 in human breast cancer. Cancer Res.
69:2195–2200. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
50.
|
Iorio MV, Visone R, Di Leva G, et al:
MicroRNA signatures in human ovarian cancer. Cancer Res.
67:8699–8707. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
51.
|
Taulli R, Bersani F, Foglizzo V, et al:
The muscle-specific microRNA miR-206 blocks human rhabdomyosarcoma
growth in xenotransplanted mice by promoting myogenic
differentiation. J Clin Invest. 119:2366–2378. 2009.PubMed/NCBI
|
|
52.
|
Negrini M and Calin GA: Breast cancer
metastasis: a microRNA story. Breast Cancer Res. 10:2032008.
View Article : Google Scholar : PubMed/NCBI
|
|
53.
|
Hobert O: miRNAs play a tune. Cell.
131:22–24. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
54.
|
Hammond SM: MicroRNAs as oncogenes. Curr
Opin Genet Dev. 16:4–9. 2006. View Article : Google Scholar
|
|
55.
|
Yang H, Zhang HY, Zhu L, Zhang CY and Li
DH: Identification and characterization of microRNAs in Macaca
fascicularis by EST analysis. Comp Funct Genom. Jul
5–2012.(Epub ahead of print).
|
|
56.
|
John B, Enright AJ, Aravin A, Tuschl T,
Sander C and Marks DS: Human MicroRNA targets. PLoS Biol.
2:e3632004. View Article : Google Scholar
|
|
57.
|
Wang D, Qiu C, Zhang H, Wang J, Cui Q and
Yin Y: Human microRNA oncogenes and tumor suppressors show
significantly different biological patterns: from functions to
targets. PLoS One. 5:e130672010. View Article : Google Scholar : PubMed/NCBI
|
|
58.
|
Yifei T, Jiajia C, Cheng L, Kaipia A and
Bairong S: MicroRNA expression analysis reveals significant
biological pathways in human prostate cancer. Systems Biology
(ISB). 2011 IEEE International Conference on 203–210.
|
|
59.
|
Wagner EF and Nebreda AR: Signal
integration by JNK and p38 MAPK pathways in cancer development. Nat
Rev Cancer. 9:537–549. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
60.
|
Sebolt-Leopold JS and Herrera R: Targeting
the mitogen-activated protein kinase cascade to treat cancer. Nat
Rev Cancer. 4:937–947. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
61.
|
O’Connell RM, Taganov KD, Boldin MP, Cheng
G and Baltimore D: MicroRNA-155 is induced during the macrophage
inflammatory response. Proc Natl Acad Sci USA. 104:1604–1609.
2007.PubMed/NCBI
|
|
62.
|
Mateescu B, Batista L, Cardon M, et al:
miR-141 and miR-200a act on ovarian tumorigenesis by controlling
oxidative stress response. Nat Med. 17:1627–1635. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
63.
|
Polo S, Pece S and Di Fiore PP:
Endocytosis and cancer. Curr Opin Cell Biol. 16:156–161. 2004.
View Article : Google Scholar
|
|
64.
|
Al-Nedawi K, Meehan B, Micallef J, et al:
Intercellular transfer of the oncogenic receptor EGFRvIII by
microvesicles derived from tumour cells. Nat Cell Biol. 10:619–624.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
65.
|
Simons M and Raposo G: Exosomes -
vesicular carriers for intercellular communication. Curr Opin Cell
Biol. 21:575–581. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
66.
|
Yasunaga J and Matsuoka M: HTLV-I and
leukemogenesis. Uirusu. 56:241–249. 2006.(In Japanese).
|
|
67.
|
Gatza ML, Watt JC and Marriott SJ:
Cellular transformation by the HTLV-I Tax protein, a
jack-of-all-trades. Oncogene. 22:5141–5149. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
68.
|
Yamaguchi H and Condeelis J: Regulation of
the actin cytoskeleton in cancer cell migration and invasion.
Biochim Biophys Acta. 1773:642–652. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
69.
|
Condeelis J, Singer RH and Segall JE: The
Great Escape: when cancer cells hijack the genes for chemotaxis and
motility. Annu Rev Cell Dev Biol. 21:6952005. View Article : Google Scholar : PubMed/NCBI
|
|
70.
|
Sahai E: Mechanisms of cancer cell
invasion. Curr Opin Genet Dev. 15:87–96. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
71.
|
Yamaguchi H, Wyckoff J and Condeelis J:
Cell migration in tumors. Curr Opin Cell Biol. 17:559–564. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
72.
|
Tominaga K, Olgun A, Smith JR and
Pereira-Smith OM: Genetics of cellular senescence. Mech Ageing Dev.
123:927–936. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
73.
|
Burkle A, Caselli G, Franceschi C, et al:
Pathophysiology of ageing, longevity and age related diseases.
Immun Ageing. 4:42007. View Article : Google Scholar : PubMed/NCBI
|
